Properties
What is it?
Combined medication Clinical-pharmacological group: Urology, Nephrology → Agents for benign prostatic hyperplasia (adenoma) → Preparations for the treatment of benign prostatic hyperplasia Composition of the medicinal product Active substance: Pumpkin seed powder, defatted 200 mg; Pumpkin seed powder purified extract, defatted, (5 – 10:1), extractant: sodium bicarbonate/table salt (purified) salt/purified water (3/6.1/90.9) – 100 mg; Goldenrod dry extract (5 – 8:1) extractant: ethanol 60 vol. % - 2.6 mg; Poplar leaf dry extract (5 – 8:1), extractant: ethanol 60 vol.% - 6.3 mg; Other ingredients (excipients): Lactose monohydrate, calcium hydrogen phosphate, cocoa powder, sucrose, gelatin, glycerin 85%, povidone K25, highly dispersed silicon dioxide, talc. Pharmacotherapeutic group Agents used for benign prostatic hyperplasia. Indications Urinary disorders in benign prostatic hyperplasia (adenoma) stages I-II; difficulty urinating, frequent urination, including at night, feeling of incomplete bladder emptying (presence of residual urine), irresistible urge to urinate. Acute and chronic prostatitis (as part of complex therapy). Interaction with other medicinal products Interaction of Prostamed with other medicinal products has not been studied at this time. Pregnancy and lactation Safety during pregnancy and breastfeeding has not been studied. Therefore, the use of Prostamed is not recommended for pregnant and breastfeeding women. Effect on the ability to drive vehicles or operate machinery Does not affect. Dosage regimen and method of administration For adults, 2-4 tablets are used 3 times a day. The tablets should be chewed, followed by a sufficient amount of liquid (approximately 1 cup of drinking water). The duration of drug use is 4 weeks.